首页 | 本学科首页   官方微博 | 高级检索  
     


125I used for labelling of proteins in an absorption model changes the absorption rate of insulin aspart
Authors:Sohoel Anders  Plum Anne  Frokjaer Sven  Thygesen Peter
Affiliation:

aDepartment of Pharmaceutics, The Danish University of Pharmaceutical Sciences, Copenhagen, Denmark

bDrug metabolism & Pharmacokinetics, Novo Nordisk, Denmark

cExploratory ADME Biopharmaceutical Research Unit, Novo Nordisk, Denmark

Abstract:The aim of this study is to validate the ability of the disappearance model to predict absorption rates of insulin aspart in pigs. The disappearance model is used as a screening tool to estimate absorption rates after subcutaneous injections in humans or pigs especially of insulin and insulin analogues. The disappearance model measures remaining radioactivity at the injection site and therefore radioactive labelling of the insulin analogue is necessary. The labelling is done with 125I. One of the assumptions for the disappearance model to be reliable is that absorption rates of the labelled and non-labelled molecules are comparable. In this study, we compared disappearance data with absorption calculated from plasma samples of insulin aspart. The calculated absorption is based on non-labelled insulin aspart. The absorption rate from the disappearance data was statistical significant (p = 0.0028) different from the absorption rate based on plasma samples. A control study was carried out where 125I labelled insulin aspart was compared to 127I (the natural non-radioactive isotope) insulin aspart. In this study, absorption rate from the disappearance data and absorption rate based on plasma samples were similar (p = 0.63). Conclusion: Iodination of insulin aspart changes the subcutaneous absorption rate.
Keywords:Disappearance   Absorption   Insulin aspart   Iodinated insulin aspart   Deconvolution
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号